Citadel Advisors’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,306
| Closed | -$22K | – | 6857 |
|
|
2023
Q2 | $22K | Sell |
1,306
-3,966,231
| -100% | -$66.9M | ﹤0.01% | 5228 |
|
|
2023
Q1 | $34.1M | Sell |
3,967,537
-298
| -0% | -$2.56K | 0.01% | 605 |
|
|
2022
Q4 | $34.2M | Buy |
3,967,835
+822,584
| +26% | +$7.08M | 0.01% | 612 |
|
|
2022
Q3 | $18.9M | Buy |
3,145,251
+2,014
| +0.1% | +$12.1K | ﹤0.01% | 859 |
|
|
2022
Q2 | $17M | Buy |
3,143,237
+420,591
| +15% | +$2.27M | ﹤0.01% | 935 |
|
|
2022
Q1 | $12.8M | Buy |
2,722,646
+1,830
| +0.1% | +$8.6K | ﹤0.01% | 1220 |
|
|
2021
Q4 | $13.4M | Sell |
2,720,816
-547
| -0% | -$2.69K | ﹤0.01% | 1214 |
|
|
2021
Q3 | $20.7M | Sell |
2,721,363
-4,404
| -0.2% | -$33.6K | ﹤0.01% | 887 |
|
|
2021
Q2 | $31.2M | Buy |
+2,725,767
| New | +$31.2M | 0.01% | 705 |
|